Investigation of dexmedetomidine concentration in breast milk during postpartum period

Investigation of dexmedetomidine concentration in breast milk during postpartum period - Investigation of dexmedetomidine concentration in breast milk during postpartum period

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014262

Enrollment

Registered

2014-06-13

Start date

2014-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnant women undergo elective cesarean section

Interventions

regulatory administration of dexmedetomidine after delivery for cesarean section

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: normal pregnant women undergo elective cesarean section

Exclusion criteria

Exclusion criteria: patientrefusal serious preexisting condition massive bleeding unexpected vital change

Design outcomes

Primary

Measure	Time frame
dexmedetomidine concentration in breast milk	—

Secondary

Measure	Time frame
dexmedetomidine concentration in blood neonatal assessment	—

Countries

Japan

Contacts

Public ContactManabu Yoshimura

Tokuyama Central Hospital department of anesthesiology

chiken2@tokuchuhp.jp0834-28-4411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026